Document:

Exhibit
10.2

 

Execution
Version

 

RESTRICTED
STOCK AGREEMENT

 

This
Restricted Stock Agreement (this “Agreement”) is made effective as of August 16, 2021 (the “Effective
Date”), by and between Streamline Health Solutions, Inc., a Delaware corporation (the “Company”),
and Badar Shaikh an individual and resident of the State of Georgia (“Shaikh”). Unless otherwise defined herein,
capitalized terms used herein shall have the meanings ascribed to them in the Unit Purchase Agreement (as defined below).

 

RECITALS

 

WHEREAS,
as part of the aggregate purchase price payable by the Company for all of the issued and outstanding units of membership interest of
Avelead Consulting, LLC, a Georgia limited liability company (“Avelead”), under that certain Unit Purchase
Agreement by and among the Company, Avelead, Shaikh, and Jawad Shaikh, an individual and resident of the State of Georgia, dated as of
the Effective Date (the “Unit Purchase Agreement”), the Company agreed to issue to Shaikh certain shares of
the Company’s common stock, par value $0.01 per share (the “Common Stock”), as part of the Closing Equity
Payment, and, if earned, as part of the First Earnout Amount and the Second Earnout Amount (collectively, the “Shares”);
and

 

WHEREAS,
the Company and Shaikh acknowledge and agree that the Shares, when and if issued, shall be subject to the terms and conditions set forth
in this Agreement.

 

Now,
therefore, in consideration of the mutual covenants and
representations set forth below, the Company and Shaikh agree as follows:

 

1.
Shares. All of the Shares when and if issued shall be deemed issued to Shaikh as fully paid and non-assessable shares, and Shaikh
shall have all rights of a stockholder with respect thereto, subject to Section 2 below. The term “Shares,” in addition
to the Shares issued pursuant to the Unit Purchase Agreement, also refers to all new, substituted or additional securities received in
replacement of the Shares, as a stock dividend or as a result of any stock split, recapitalization, merger, reorganization, exchange
for other securities, by reclassification, or the like, and all new, substituted or additional securities or other properties to which
Shaikh is entitled by reason of Shaikh’s ownership of the Shares. 

 

2.
Restrictions. The Shares issued to Shaikh pursuant to the terms of the Unit Purchase Agreement shall be subject, in addition to
restrictions imposed by applicable securities laws, to the following transfer restrictions: 

 

2.1
(i) the Shares shall be “restricted shares” within the meaning of Regulation D and Rule 144 under the Securities Act of 1933,
as amended (the “Act”), and may not be offered or sold unless such offer or sale is registered under the Act
or an exemption from registration is available; (ii) the provisions of Rule 144 under the Act shall permit resale of the Shares only
under limited circumstances and such Shares must be held by Shaikh for at least six (6) months following issuance of such Shares before
they can be resold pursuant to Rule 144 and then may be resold only in accordance with the requirements of Rule 144 (and any other applicable
legal requirements); (iii) Shaikh hereby agrees to comply with the requirements of Rule 144 applicable to affiliates of the Company (even
if Shaikh is not an affiliate of the Company under the Act), that impose limitations on the amount of securities sold in any three-month
period by affiliates of the Company under Rule 144(e) (it being understood that such requirements shall apply despite Shaikh’s
separation from Avelead pursuant to that certain Confidential Separation Agreement and General Release of Claims by and between Shaikh
and Avelead); and (iv) Shaikh hereby agrees to not permit the Shares to be encumbered by any Lien (as defined in the Unit Purchase Agreement)
within six (6) months following issuance of such Shares; provided, that the restrictions in Section 2.1(iii) shall expire
upon the earliest to occur of the following events: (a) the conclusion of the Second Earnout Measurement Period (as defined in the Unit
Purchase Agreement), (b) the date on which Shaikh holds less than 1% of the issued and outstanding voting securities of the Company,
on a fully diluted basis, or (c) upon a Change of Control Transaction (as defined in the Unit Purchase Agreement); provided further,
that the restrictions in Section 2.1(iii) shall not apply if such resales are approved in writing by the Company prior to their execution;

 

     

     

    

 

2.2
Shaikh shall be considered a “Restricted Person” under the Company’s Insider Trading Policy (the “Insider
Trading Policy”) and shall be prohibited from conducting any sale of the Shares or any other shares of Common Stock held
by Shaikh other than during a “trading window” set forth in an email to Restricted Persons prior to the beginning of such
trading window; and the Company may, at any time, impose a “blackout” period pursuant to the Insider Trading Policy, during
which period buying, selling or otherwise transferring securities by a specified group of insiders, which group of insiders may include
Shaikh, would be considered inappropriate; provided, that the restrictions in this Section 2.2 shall expire upon the termination
of the restrictions in Section 2.1(iii) above at a time when Shaikh would not otherwise be deemed to be a “Restricted Person”
under the terms of the Insider Trading Policy; and

 

2.3
Shaikh shall be prohibited from conducting any open-market sale of the Shares or any other shares of Common Stock held by Shaikh during
the thirty (30) trading days immediately prior to the last day of the First Earnout Measurement Period and Second Earnout Measurement
Period, as applicable.

 

3.
Representations and Warranties of Shaikh. In connection with the issuance of the Shares pursuant to the terms of the Unit Purchase
Agreement, Shaikh represents, warrants and acknowledges to the Company that: 

 

3.1
Shaikh possesses all requisite capacity, power and authority (corporate and other) to execute and deliver this Agreement and to perform
his obligations hereunder;

 

3.2
neither the execution and delivery by Shaikh of this Agreement, nor the performance by Shaikh of his obligations hereunder will (i) require
on the part of Shaikh any notice to or filing with, or any permit, authorization, consent or approval of, any governmental entity, or
(ii) violate any order, writ, injunction, decree, statute, rule or regulation applicable to Shaikh or any of his properties or assets,
except in the cases of (i) and (ii) where any violation or failure to deliver a notice or submit a filing would not cause a material
adverse effect;

 

3.3
the Shares to be acquired by Shaikh pursuant to the Unit Purchase Agreement will be acquired for Shaikh’s own account and not with
a view to, or intention of, distribution thereof in violation of the Act, or any other applicable securities laws, and the Shares will
not be disposed of in contravention of the Act or any applicable securities laws;

 

3.4
Shaikh is an “accredited investor” within the meaning of Regulation D under the Act; and

 

3.5
the Shares are not registered under the Act on the basis that the issuance of securities hereunder is exempt from registration under
the Act pursuant to Section 4(a)(2) thereof and the rules and regulations promulgated thereunder, and that the Company’s reliance
on such exemption is predicated on Shaikh’s representations set forth herein.

 

    	2

     

    

 

4.
Representations and Warranties of the Company. In connection with the issuance of the Shares pursuant to the terms of the Unit
Purchase Agreement, the Company represents, warrants and acknowledges to Shaikh that: 

 

4.1
the Company is a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation and
has all requisite power and authority (corporate and other) to carry on the businesses in which it is engaged and to own and use the
properties owned and used by it, and is qualified to do business and is in good standing in every jurisdiction in which the operation
of the business of the Company requires it to be so qualified;

 

4.2
the Company has all requisite capacity, power and authority (corporate or other) to execute and deliver this Agreement, to perform its
obligations hereunder, and to issue the Shares to Shaikh;

 

4.3
the execution and delivery by the Company of this Agreement, the performance by the Company of its obligations in this Agreement, and
the issuance of the Shares contemplated hereby have been duly and validly authorized by all necessary corporate and other action on the
part of the Company;

 

4.4
neither the execution and delivery by the Company of this Agreement, nor the performance by the Company of its obligations hereunder,
nor the issuance of the Shares contemplated hereby, will (i) conflict with or violate any provision of the Company’s articles of
incorporation, by-laws, voting agreements or similar documents, instruments or agreements relating to the organization or governance
of the Company (collectively, the “Organizational Documents”), each as amended or restated to date, (ii) require
on the part of the Company any notice to or filing with, or any permit, authorization, consent or approval of, any governmental entity,
or (iii) violate any order, writ, injunction, decree, statute, rule or regulation applicable to the Company or any of its properties
or assets, except in the cases of (ii) and (iii) where any violation or failure to deliver a notice or submit a filing would not cause
a material adverse effect;

 

4.5
the Shares subject to issuance pursuant to the terms of the Unit Purchase Agreement, upon issuance on the terms and conditions specified
herein and the Unit Purchase Agreement, will be duly authorized, validly issued, fully paid and non-assessable, free and clear of all
liens and restrictions (other than restrictions on transfer imposed herein and under the Act or any other applicable securities laws),
and not subject to or issued in violation of any purchase option, call option, right of first refusal, preemptive right, subscription
right or any similar right under any provision of the Delaware General Corporation Law, the Organizational Documents or any agreement
to which the Company is a party or is otherwise bound;

 

4.6
the Company has filed all registration statements, forms, reports, certifications and other documents (collectively, “SEC
Reports”) required to be filed by the Company with the United States Securities and Exchange Commission (the “SEC”)
and all of the Company’s SEC Reports (i) have been filed on a timely basis, (ii) at the time filed, complied as to form in all
material respects with the requirements of the Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
applicable to such SEC Reports, and (iii) did not, at the time they were filed, contain any untrue statement of a material fact or omit
to state a material fact required to be stated in such SEC Reports or necessary in order to make the statements in such SEC Reports,
in light of the circumstances under which they were made, not misleading, in any material respect; and

 

4.7
the Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company has not (i) received any written notification
that the SEC is contemplating terminating such registration or (ii) received written notice from The NASDAQ Stock Market LLC (“Nasdaq”)
to the effect that the Company is not in compliance with the listing or maintenance requirements of such market or exchange.

 

    	3

     

    

 

5.
Securities Matters. With a view to making available to Shaikh the benefits of Rule 144 under the Act and any other rule or regulation
of the SEC that may at any time permit a stockholder to sell Common Stock to the public without registration under the Act, Company will: 

 

5.1
make and keep available adequate current public information, as those terms are understood and defined in Rule 144 under the Act, at
all times after the Effective Date;

 

5.2
use commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under
the Exchange Act; and

 

5.3
furnish to Shaikh, so long as he owns at least 1% of the issued and outstanding voting securities of the Company, on a fully diluted
basis, reasonably promptly upon request (i) to the extent accurate, a written statement by the Company that it has complied with the
reporting requirements of Rule 144, the Securities Act, and the Exchange Act; and (ii) such other information as may be reasonably requested
in availing Shaikh of any rule or regulation of the SEC that permits the selling of any such securities without registration.

 

6.
Legends. Shaikh acknowledges and agrees that the Shares shall be uncertificated and in book entry form and stop transfer instructions
shall be given to the Company’s stock transfer agent with respect to the Shares which shall be notated with the legend substantially
as follows: 

 

THE
SHARES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY
STATE SECURITIES LAWS, AND MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES
UNDER SAID ACT OR AN EXEMPTION FROM SUCH REGISTRATION UNDER THE ACT. THE SHARES ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AS SET
FORTH IN THAT CERTAIN RESTRICTED STOCK AGREEMENT BETWEEN THE COMPANY AND THE HOLDER.

 

7.
General Provisions.

 

7.1
Notices. All notices, requests, demands, claims, and other communications hereunder shall be in writing (including by email).
Any notice, request, demand, claim or other communication hereunder shall be deemed duly received on the date of receipt by the recipient
thereof if received on a business day in the place of receipt prior to 5:00 p.m. Otherwise, any such notice, request or communication
shall be deemed not to have been received until the next succeeding business day in the place of receipt.

 

If
to the Company, to:

 

Streamline
Health Solutions, Inc.

11800 Amber Park Drive, Suite 125

Alpharetta, GA 30009

Attention:
Thomas J. Gibson

Email: thomas.gibson@streamlinhealth.net

 

With
a copy (which shall not constitute notice) to:

 

Morris,
Manning & Martin, LLP

3343 Peachtree Road, N.E.

1600 Atlanta Financial Center

Atlanta, Georgia 30326

Attention: David M. Calhoun

Phone: (404) 504-7613

Facsimile: (404) 365-9532

E-Mail: dmc@mmmlaw.com

 

    	4

     

    

 

If
to Shaikh, to:

 

Badar
Shaikh

P.O. Box 669

Buford, GA 30515

E-Mail: GodMode@rokra.net

 

With
a copy (which shall not constitute notice) to:

 

Kilpatrick
Townsend & Stockton LLP

1100 Peachtree Street, N.E., Suite 2800

Atlanta, GA 30309-4530

Attention: Louis Barbieri III

Phone: (404) 815-6079

Facsimile: (404) 541-3141

E-Mail: lbarbieri@kilpatricktownsend.com

 

7.2
Further Assurances. From time to time after the date hereof, upon reasonable notice and without further consideration, Shaikh
and the Company shall execute and deliver any other document or instrument and shall take any other action as may be necessary in the
reasonable discretion of the Company or any stock transfer agent to give effect to or evidence the provisions of this Agreement.

 

7.3
Assignment. Except as otherwise expressly provided herein, neither party may assign rights or delegate duties arising hereunder
without the prior written consent of the other party. Any assignment or delegation of any right, duty, or claim arising hereunder without
such consent shall be void.

 

7.4
Entire Agreement. This Agreement and the Unit Purchase Agreement constitute the exclusive statement of the agreement of the Company
and Shaikh concerning the matters set forth herein, including with respect to rights of and restrictions on the Shares and supersedes
all other agreements, oral or written, among or between any of them concerning rights of and restrictions on the Shares.

 

7.5
Modification and Waiver. No amendment, modification, or waiver of this Agreement shall be effective unless made in a written instrument
which specifically references this Agreement and which is signed by the Company and Shaikh. Except as expressly provided herein, the
failure of the Company or Shaikh to enforce at any time, or for any period of time, any provisions of this Agreement shall not be construed
as a waiver of any provision or of the right of any such party to enforce each and every provision of this Agreement.

 

7.6
Binding Effect. This Agreement shall be binding upon and inure to the benefit of Shaikh and its successors and assigns, shall
be binding upon and inure to the benefit of the Company and its successors and assigns.

 

7.7
Governing Law. THIS AGREEMENT IS GOVERNED BY AND SHALL BE CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE EXCLUDING
ANY CONFLICT OF LAWS RULE OR PRINCIPLE THAT MIGHT REFER THE GOVERNANCE OR THE CONSTRUCTION OF THIS AGREEMENT TO THE LAW OF ANOTHER JURISDICTION.

 

    	5

     

    

 

7.8
Waiver of Jury Trial. The parties to this Agreement each hereby waive, to the fullest extent permitted by law, any right to trial
by jury of any claim, demand, action, or cause of action (i) arising under this Agreement or (ii) in any way connected with or related
or incidental to the dealings of the parties hereto in respect of this Agreement or any of the transactions related hereto, in each case
whether now existing or hereafter arising, and whether in contract, tort, equity, or otherwise. The parties to this Agreement each hereby
agree and consent that any such claim, demand, action, or cause of action shall be decided by court trial without a jury and that the
parties to this Agreement may file an original counterpart of a copy of this Agreement with any court as written evidence of the consent
of the parties hereto to the waiver of their right to trial by jury.

 

7.9
Severability and Reformation. If any provision of this Agreement, or the application thereof to any person or circumstance should,
for any reason and to any extent, be invalid or unenforceable, the remainder of this Agreement and the application of such provision
to other persons or circumstances shall not be affected thereby, but rather shall be enforced to the greatest extent permitted by law.

 

7.10
Headings. The headings contained in this Agreement are intended solely for convenience of reference and shall not be considered
in interpreting this Agreement.

 

7.11
Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, and all of which
together shall constitute one and the same instrument.

 

7.12
Third Parties. Nothing expressed or implied in this Agreement is intended or shall be construed to confer on any person, other
than the Company and Shaikh, any rights hereunder.

 

[Signatures
on next page.]

 

    	6

     

    

  

IN
WITNESS WHEREOF, the parties have duly executed this Restricted Stock Agreement as of the day and year first set forth above.

 

	COMPANY:	STREAMLINE
    HEALTH SOLUTIONS, INC.
	 	 	 
	 	By:
    	/s/
    Thomas J. Gibson
	 	Name:
    	Thomas
    J. Gibson
	 	Title:	Chief
    Financial Officer
	 	 	 
	SHAIKH:	/s/ Badar Shaikh
	 	Badar Shaikh

 

[Signature Page to Restricted Stock Agreement]Exhibit
10.3

 

EMPLOYMENT
AGREEMENT

 

This
EMPLOYMENT AGREEMENT (together with Exhibits A and B attached hereto, the “Agreement”) is entered into
as of August 16, 2021 (the “Effective Date”), by and between AVELEAD CONSULTING, LLC, a Georgia limited liability company
with its headquarters at 1172 Satellite Boulevard, Suwanee, Georgia 30024 (the “Company”), and JAWAD SHAIKH, a resident of
the state of Georgia (“Executive”).

 

RECITALS:

 

WHEREAS,
the Company and Executive hereby agree that Executive will serve as an officer of the Company and wish to establish the terms of the
Executive’s employment with the Company, the financial obligations of the Company to the Executive and to specify certain rights,
responsibilities and duties of the Executive; and

 

WHEREAS,
the Company is a wholly-owned subsidiary of Streamline Health Solutions, Inc., a Delaware corporation (“Parent”);

 

WHEREAS,
the Company and Executive hereby agree that Parent and the Company’s other Affiliates are intended third party beneficiaries of
this Agreement, with full rights to enforce this Agreement (as used herein, with respect to Parent, “Affiliate” means any
entity controlled by Parent, and with respect to the Company, “Affiliate” means any entity that controls, is controlled by,
or is under common control with the Company, in each case whether or not such entity is currently in existence);

 

WHEREAS,
the Company and the Executive hereby agree that the Executive will serve as the President & Chief Executive Officer of the Company
pursuant to the terms and conditions set forth in this Agreement and will report directly to the Chief Executive Officer of Parent (“CEO”).

 

NOW,
THEREFORE, in consideration of the premises and the agreements contained herein, and for other good and valuable consideration, the
receipt and adequacy of which the parties hereby acknowledge, the parties agree as follows:

 

1.
EMPLOYMENT

 

The
Company hereby agrees to employ Executive, and Executive, in consideration of such employment and other consideration set forth herein,
hereby accepts employment, upon the terms and conditions set forth herein.

 

2.
POSITION AND DUTIES

 

During
the Term (as defined in Section 10 of this Agreement), Executive will be employed as the President & Chief Executive Officer of the
Company and may also serve as an officer or director of the Company for no additional compensation, as part of Executive’s services
to the Company hereunder. While employed hereunder, Executive will do all things necessary, legal and incident to the above positions,
and otherwise will perform such executive-level functions as designated by the CEO.

 

3.
COMPENSATION AND BENEFITS

 

Subject
to such modifications as may be contemplated by Exhibit A and approved from time to time by the Board or the Compensation Committee
of the Board (the “Committee”), and unless otherwise consented to by Executive, Executive will receive the compensation and
benefits listed on the attached Exhibit A, which is incorporated herein and expressly made a part of this Agreement. Such compensation
and benefits will be paid and provided by the Company in accordance with the Company’s regular payroll, compensation and benefits
policies.

 

    	1

     

    

 

4.
EXPENSES

 

The
Company will pay or reimburse Executive for all travel and out-of-pocket expenses reasonably incurred or paid by Executive in connection
with the performance of Executive’s duties as an employee of the Company upon compliance with the Company’s procedures for
expense reimbursement, including the presentation of expense statements or receipts or such other supporting documentation as the Company
may reasonably require. All expenses eligible for reimbursements in connection with the Executive’s employment with the Company
must be incurred by Executive during the term of employment and must be in accordance with the Company’s expense reimbursement
policies. The amount of reimbursable expenses incurred in one taxable year will not affect the expenses eligible for reimbursement in
any other taxable year. Each category of reimbursement will be paid as soon as administratively practicable, but in no event will any
such reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. No right
to reimbursement is subject to liquidation or exchange for other benefits.

 

5.
BINDING AGREEMENT

 

The
Parent and Company warrant and represent to Executive that the Company, acting by the officer executing this Agreement on its behalf,
has the full right and authority to enter into this Agreement and to perform all of its obligations hereunder.

 

6.
OUTSIDE EMPLOYMENT

 

Executive
will devote his full time and attention to the performance of the duties incident to Executive’s position with the Company, and
will not have any other employment with any other enterprise or substantial responsibility for any enterprise which would be inconsistent
with Executive’s duty to devote Executive’s full time and attention to Company matters; provided, however, that the
foregoing will not prevent Executive from being a director or owner of the entities listed on Exhibit B (the “Exempted Entities”)
hereto or Executive’s participation in any charitable or civic organization or, subject to CEO consent, which consent will not
be unreasonably withheld, from service in a non-executive capacity on the boards of directors of up to two (2) other companies that do
not interfere with Executive’s performance of the duties and responsibilities to be performed by Executive under this Agreement.

 

7.
CONFIDENTIAL INFORMATION AND TRADE SECRETS

 

The
Company is in the business of providing solutions, including comprehensive suites of health information management solutions relating
to revenue integrity, enterprise content management, process management, financial deposit and contract reconciliation, price transparency
and compliance, computer assisted coding, business analytics, clinical analytics and integrated workflow systems, that help hospitals,
physician groups and other healthcare organizations improve efficiencies and business processes across the enterprise to enhance and
protect revenues, offering a flexible, customizable way to optimize the clinical and financial performance of any healthcare organization
(collectively, the “Business”).

 

    	2

     

    

 

For
the purpose of this Agreement, “Confidential Information” will mean any written or unwritten information which relates to
or is used in the Business including, without limitation, the Company’s services, processes, patents, systems, equipment, creations,
designs, formats, programming, discoveries, inventions, improvements, computer programs, data kept on computers, engineering, research,
development, applications, financial information, information regarding services and products in development, market information, including
test marketing or localized marketing, other information regarding processes or plans in development, trade secrets, training manuals,
know-how of the Company, and the customers, clients, suppliers and others with whom the Company does or has in the past done, business
(including any information about the identity of the Company’s customers or suppliers and written customer lists and customer prospect
lists), or information about customer requirements, transactions, work orders, pricing policies, plans or any other Confidential Information,
which the Company deems confidential and proprietary and which is generally not known to others outside the Company and which gives or
tends to give the Company a competitive advantage over persons who do not possess such information or the secrecy of which is otherwise
of value to the Company in the conduct of its business — regardless of when and by whom such information was developed or acquired,
and regardless of whether any of these are described in writing, reduced to practice, copyrightable or considered copyrightable, patentable
or considered patentable. For the avoidance of doubt, Executive acknowledges and agrees that “Confidential Information” will
include the Confidential Information of the Company as well as the Confidential Information of its Affiliates.

 

“Confidential
Information” will not include general industry information or information which is publicly available or is otherwise in the public
domain without breach of this Agreement, information which Executive has lawfully acquired from a source other than through his employment
with the Company, or information which is required to be disclosed pursuant to any law, regulation or rule of any governmental body or
authority or court order (in which event Executive will immediately notify the Parent and the Company of such requirement or order so
as to give the Company an opportunity to seek a protective order or other manner of protection prior to production or disclosure of the
information). Executive acknowledges that Confidential Information is novel and proprietary to and of considerable value to the Company.

 

Confidential
Information will also include confidential information of third parties, clients or prospective clients that has been provided to the
Company or to Executive in conjunction with Executive’s employment, which information the Company is obligated to treat as confidential.
Confidential Information does not include information voluntarily disclosed to the public by the Company, except where such public disclosure
has been made by the Executive without authorization from the Company, or which has been independently developed and disclosed by others,
or which has otherwise entered the public domain through lawful means.

 

Notwithstanding
anything to the contrary set forth in this Agreement, pursuant to the Defend Trade Secrets Act of 2016 (18 U.S.C. § 1833(b)(1)),
no individual shall be held criminally or civilly liable under federal or state law for the disclosure of a trade secret that: (1) is
made (x) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (y) solely
for the purpose of reporting or investigating a suspected violation of law; or (2) is made in a complaint or other document filed in
a lawsuit or other proceeding, if such filing is made under seal.

 

Executive
acknowledges that all Confidential Information is the valuable, unique and special asset of the Company and its Affiliates and that the
Company and its Affiliates, as applicable, own the sole and exclusive right, title and interest in and to this Confidential Information.

 

(a)
To the extent that the Confidential Information rises to the level of a trade secret under applicable law, then Executive will,
during Executive’s employment and for as long thereafter as the Confidential Information remains a trade secret (or for the
maximum period of time otherwise allowed under applicable law) protect and maintain the confidentiality of these trade secrets and
refrain from disclosing, copying or using the trade secrets without the Company’s prior written consent, except as necessary
in Executive’s performance of Executive’s duties while employed with the Company.

 

    	3

     

    

 

(b)
To the extent that the Confidential Information defined above does not rise to the level of a trade secret under applicable law,
Executive will not, during Executive’s employment and thereafter for a period of two (2) years, disclose, or cause to be
disclosed in any way, Confidential Information, or any part thereof, to any person, firm, corporation, association or any other
operation or entity, or use the Confidential Information on Executive’s own behalf, for any reason or purpose except as
necessary in the performance of his duties while employed with the Company. Executive further agrees that, during Executive’s
employment and thereafter for a period of two (2) years, Executive will not distribute, or cause to be distributed, Confidential
Information to any third person or permit the reproduction of Confidential Information, except on behalf of the Company in
Executive’s capacity as an employee of the Company. Executive will take all reasonable care to avoid unauthorized disclosure
or use of the Confidential Information. Executive agrees that all restrictions contained in this Section 7 are reasonable and valid
under the circumstances and hereby waives all defenses to the strict enforcement thereof by the Company.

 

Executive
agrees that, upon the request of the Company, or in any event immediately upon termination of his employment for whatever reason, Executive
will immediately deliver up to the Company or its designee all Confidential Information in Executive’s possession or control, and
all notes, records, memoranda, correspondence, files and other papers, and all copies thereof, relating to or containing Confidential
Information. Executive does not have, nor can Executive acquire, any property or other rights in Confidential Information.

 

For
purposes of this Section 7, the term “Company” shall be deemed to include the Parent and the Company’s Affiliates.

 

8.
PROPERTY OF THE COMPANY

 

All
ideas, inventions, discoveries, proprietary information, know-how, processes and other developments and, more specifically, improvements
to existing inventions, conceived by Executive, alone or with others, during the term of Executive’s employment with the Company,
whether or not during working hours and whether or not while working on a specific project, that are within the scope of the Company’s
Business operations or that relate to any work or projects of the Company, are and will remain the exclusive property of the Company.
Inventions, improvements and discoveries relating to the products and services of the Company conceived or made by Executive, either
alone or with others, while employed with the Company are conclusively and irrefutably presumed to have been made during the period of
employment and are the sole property of the Company. The Executive will promptly disclose in writing any such matters to the Company
but to no other person without the consent of the Parent. Executive hereby assigns and agrees to assign all right, title and interest
in and to such matters to the Company. Executive will, upon request of the Company, execute such assignments or other instruments and
assist the Company in the obtaining, at the Company’s sole expense, of any patents, trademarks or similar protection, if available,
in the name of the Company.

 

For
purposes of this Section 8, the term “Company” shall be deemed to include Parent and the Company’s Affiliates.

 

    	4

     

    

 

9.
PROTECTIVE COVENANTS

 

(a) Non-Solicitation
of Customers or Clients. During Executive’s employment and for a period of two (2) years following the date of any
voluntary or involuntary termination of Executive’s employment for any reason, Executive agrees not to solicit, directly or
indirectly (including by assisting others), any revenue or bookings from any of the Company’s customers or clients, including
actively sought prospective customers or clients, with whom Executive has had material contact during Executive’s employment
with the Company, for the purpose of providing products or services that are competitive with those provided by the Company in the
last twelve (12) months of Executive’s employment with the Company. As used in this paragraph, “material contact”
means the contact between Executive and each customer, client or vendor, or potential customer or client (i) with whom or which
Executive dealt on behalf of the Company, (ii) whose dealings with the Company were coordinated or supervised by Executive, (iii)
about whom Executive obtained confidential information in the ordinary course of business as a result of Executive’s
association with the Company, or (iv) who receives products or services authorized by the Company, the sale or provision of which
products or services results or resulted in compensation, commissions or earnings for Executive within two years prior to the date
of the Executive’s termination.

 

(b)
Non-Piracy of Employees. During Executive’s employment and for a period of two (2) years following the date of any voluntary
or involuntary termination of Executive’s employment for any reason, Executive covenants and agrees that Executive will not,
directly or indirectly, within the Territory, as defined below: (i) solicit, recruit or hire (or attempt to solicit, recruit or
hire) or otherwise assist anyone in soliciting, recruiting or hiring, any employee or independent contractor of the Company who
performed work for the Company and worked with Executive within the last year of Executive’s employment with the Company, or
(ii) otherwise encourage, solicit or support any such employee or independent contractor to leave his or her employment or
engagement with the Company.

 

(c)
Non-Compete. During Executive’s employment with the Company and (i) for a period of two (2) years following the date of any
termination of Executive’s employment for any reason other than termination of Executive’s employment by the Company
without Good Cause or by the Executive for Good Reason or (ii) for a period of one (1) year following the date of any termination of
Executive’s employment with the Company by the Company without Good Cause or by the Executive for Good Reason; and provided in
each of (i) and (ii) that the Company is not in default of its obligations specified in Sections 3, 11 and 13 hereof, Executive
agrees not to, directly or indirectly, compete with the Company, as an officer, director, member, principal, partner, shareholder,
owner, manager, supervisor, administrator, employee, consultant or independent contractor, by working for a competitor to, or
engaging in competition with, the Business, in the Territory, in a capacity in which Executive performs duties and responsibilities
that are the same as or similar to the duties performed by Executive while employed by the Company, provided that the foregoing will
not prohibit Executive from (x) owning not more than 5% of the outstanding stock of a corporation subject to the reporting
requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or (y) owning or serving as a
director of any Exempted Entity. The “Territory” will be defined to be that geographic area comprised of the following
states in the United States of America, the District of Columbia, and the Canadian provinces of Quebec and Alberta:

 

	Alabama	Indiana	Nebraska	South
    Carolina
	Alaska	Iowa	Nevada	South
    Dakota
	Arizona	Kansas	New
    Hampshire	Tennessee
	Arkansas	Kentucky	New
    Jersey	Texas
	California	Louisiana	New
    Mexico	Utah
	Colorado	Maine	New
    York	Vermont
	Connecticut	Maryland	North
    Carolina	Virginia
	Delaware	Massachusetts	North
    Dakota	Washington
	Florida	Michigan	Ohio	West
    Virginia
	Georgia	Minnesota	Oklahoma	Wisconsin
	Hawaii	Mississippi	Oregon	Wyoming
	Idaho	Missouri	Pennsylvania	 
	Illinois	Montana	Rhode
    Island	 

 

provided,
however, that the Territory described herein is a good faith estimate of the geographic area that is now applicable as the area in
which the Company does or will do business during the term of Executive’s employment, and the Company and Executive agree that
this non-compete covenant will ultimately be construed to cover only so much of such Territory as relates to the geographic areas in
which the Executive does business for and on behalf of the Company within the one-year period preceding termination of Executive’s
employment.

 

    	5

     

    

 

For
purposes of this Section 9, the term “Company” shall be deemed to include Parent and the Company’s Affiliates.

 

10.
TERM

 

Unless
earlier terminated pursuant to Section 11 herein, the term of this Agreement will be for a period beginning on the start date specified
in Exhibit A and ending on the date of the two-year anniversary of the start date specified in Exhibit A (the “Initial
Term”). Upon expiration of the Initial Term, this Agreement will automatically renew in successive one-year periods (each a “Renewal
Period”), unless Executive or the Company notifies the other party at least 60 days prior to the end of the Initial Term or the
applicable Renewal Period that this Agreement will not be renewed. The Initial Term, and, if this Agreement is renewed in accordance
with this Section 10, each Renewal Period, will be included in the definition of “Term” for purposes of this Agreement. Unless
waived in writing by the Company, the requirements of Section 7 (Confidential Information and Trade Secrets), Section 8 (Property of
the Company) and Section 9 (Protective Covenants) will survive the expiration or termination of this Agreement or Executive’s employment
for any reason.

 

11.
TERMINATION

 

Executive’s
employment is at-will but the benefits, if any, Executive receives upon termination are dependent on the reason for termination and are
described below in this Section 11.

 

(a) Death.
This Agreement and Executive’s employment hereunder will be terminated on the death of Executive, effective as of the date of
Executive’s death. In such event, the Company will pay to the estate of Executive the sum of (i) accrued but unpaid base
salary earned prior to Executive’s death (to be paid in accordance with normal practices of the Company), and (ii) expenses
incurred by Executive prior to his death for which Executive is entitled to reimbursement under (and paid in accordance with)
Section 4 herein.

 

(b)
Continued Disability. This Agreement and Executive’s employment hereunder may be terminated, at the option of the Company,
upon a Continued Disability (as defined herein) of Executive. For the purposes of this Agreement, and unless otherwise required under
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), “Continued Disability” will be defined
as the inability or incapacity (either mental or physical) of Executive to continue to perform Executive’s duties hereunder for
a continuous period of one hundred twenty (120) working days, or if, during any calendar year of the Term hereof because of disability,
Executive will have been unable to perform Executive’s duties hereunder for a total period of one hundred eighty (180) working
days regardless of whether or not such days are consecutive. The determination as to whether Executive is unable to perform the essential
functions of Executive’s job will be made by the Board or the Committee in its reasonable discretion; provided, however, that
if Executive is not satisfied with the decision of the Board or the Committee, Executive will submit to examination by three competent
physicians who practice in the metropolitan area in which the Company maintains its principal executive office, one of whom will be selected
by the Company, another of whom will be selected by Executive, with the third to be selected by the physicians so selected. The determination
of a majority of the physicians so selected will supersede the determination of the Board or the Committee and will be final and conclusive.
In the event of the termination of Executive’s employment due to Continued Disability, the Company will pay to Executive the sum
of (i) accrued but unpaid base salary earned prior to the date of the Executive’s termination of employment due to Continued Disability
(paid in accordance with the normal practices of the Company), and (ii) expenses incurred by Executive prior to his termination of employment
for which Executive is entitled to reimbursement under (and paid in accordance with) Section 4 herein, and Executive will be entitled
to no severance or other post-termination benefits.

 

    	6

     

    

 

(c) Termination
by the Company for Good Cause, by Executive Other Than for Good Reason, or upon Non-Renewal of the Term by Either Party.
Notwithstanding any other provision of this Agreement, the Company may at any time terminate this Agreement and Executive’s
employment hereunder for Good Cause, Executive may at any time terminate his employment other than for Good Reason (as defined in
Section 11(d) herein), or Executive may notify the Company that he will not renew the Term. For this purpose, “Good
Cause” will include the following: the current use of illegal drugs; conviction of any crime which involves moral turpitude,
fraud or misrepresentation; commission of any act which results in a conviction of Executive of a felony or which in the good faith
opinion of the Board materially adversely impacts the business or reputation of the Company; fraud; misappropriation or embezzlement
of Company funds or property; willful misconduct or grossly negligent or reckless conduct which is materially injurious to the
reputation, business or business relationships of the Company; material violation or default on any of the provisions of this
Agreement; or material and continuous failure to meet reasonable performance criteria or reasonable standards of conduct as
established from time to time by the Board, which failure continues for at least 30 days after written notice from the Company to
Executive. Notice of a termination by the Company for Good Cause will be delivered in writing to Executive stating the Good Cause
for such action. If the employment of Executive is terminated by the Company for Good Cause, if Executive terminates employment for
any reason other than for Good Reason (including, but not limited to, resignation), or if either party notifies the other party of
non-renewal of the Term in accordance with Section 10 herein, then, the Company will pay to Executive the sum of (i) accrued but
unpaid salary through the termination date (paid in accordance with the normal practices of the Company), and (ii) expenses incurred
by Executive prior to his termination date for which Executive is entitled to reimbursement under (and paid in accordance with)
Section 4 herein, and Executive will be entitled to no severance or other post-termination benefits.

 

(d)
Termination by the Company without Good Cause or by Executive for Good Reason. The Company may terminate this Agreement and Executive’s
employment at any time without Good Cause (as “Good Cause” is defined in Section 11(c) above), or Executive may terminate
his employment at any time for Good Reason. For the purposes herein, “Good Reason” will mean (i) a material diminution of
Executive’s base salary; (ii) a material diminution in Executive’s authority, duties, or responsibilities; (iii) any other
action or inaction that constitutes a material breach of the terms of this Agreement or that certain letter agreement regarding board
observer rights, dated as of the date hereof, by and between Parent, Executive, and Badar Shaikh or (iv) change in Executive’s
principal place of reporting to the Company more than fifty (50) miles outside the Atlanta metropolitan area; provided that Executive’s
termination will not be treated as for Good Reason unless Executive provides the Company with notice of the existence of the condition
claimed to constitute Good Reason within 45 days of the initial existence of such condition, the Company fails to remedy such condition
within 30 days following the Company’s receipt of such notice, and Executive resigns within 30 days after the end of the Company’s
cure period. In the event that (i) the Company terminates the employment of Executive during the Term without Good Cause or (ii) Executive
terminates employment for Good Reason, then the Company will pay Executive the sum of (A) accrued but unpaid salary through the termination
date, and payments of any bonuses and commission earned and payable for up to 90 days following the termination date (as paid in accordance
with the normal practices of the Company), (B) expenses incurred by Executive prior to his termination date for which Executive is entitled
to reimbursement under (and paid in accordance with) Section 4 herein, and (C) provided that Executive is not in default of his obligations
under Section 7, 8, or 9 herein, an amount equal to six months’ base salary ((A) through (C), being hereinafter referred to, collectively,
as the “Separation Benefits”). In such event, the payments described in (C) in the preceding sentence will be made following
Executive’s execution (and non-revocation) of a form of general release of claims as is acceptable to the Board or the Committee
if the general release form is provided to the Executive within one month of the Executive’s date of termination, in accordance
with the normal payroll practices of the Company; provided that the portion of the severance payment described in clause (C) above that
exceeds the “separation pay limit,” if any, will be paid to the Executive in a lump sum payment within thirty (30) days following
the date of Executive’s termination of employment (or such earlier date following the date of Executive’s termination of
employment, if any, as may be required under applicable wage payment laws), but in no event later than the fifteenth (15th) day of the
third (3rd) month following the Executive’s date of termination. The “separation pay limit” will mean two (2) times
the lesser of: (1) the sum of Executive’s annualized compensation based upon the annual rate of pay for services provided to the
Company for the calendar year immediately preceding the calendar year in which Executive’s date of termination of employment occurs
(adjusted for any increase during that calendar year that was expected to continue indefinitely if Executive had not terminated employment);
and (2) the maximum dollar amount of compensation that may be taken into account under a tax-qualified retirement plan under Code Section
401(a)(17) for the year in which his termination of employment occurs. The lump-sum payment to be made to Executive pursuant to this
Section 11(d) is intended to be exempt from Code Section 409A under the exemption found in Regulation Section 1.409A-1(b)(4) for short-term
deferrals. The remaining portion of the severance payment described in clause (C) above will be paid in periodic installments over the
12-month period commencing on the first post-termination payroll date following expiration of the revocation period described above and
will be paid in accordance with the normal payroll practices of the Company. Notwithstanding the foregoing, in no event will such remaining
portion of the severance payment described in clause (C) above be paid to Executive later than December 31 of the second calendar year
following the calendar year in which Executive’s date of termination of employment occurs. The payments to be made to Executive
pursuant to the immediately preceding sentence are intended to be exempt from Code Section 409A under the exemption found in Regulation
Section 1.409A-1(b)(9)(iii) for separation pay plans (i.e., the so-called “two times” pay exemption). For the sake
of clarity, no election by the Company not to renew the Term will trigger any rights to severance or other benefits.

 

    	7

     

    

 

(e)
Payment of COBRA Premiums. In the event that the Company terminates Executive’s employment for any reason other than Good
Cause or Executive terminates his employment for Good Reason, then, provided that Executive timely elects to receive continued
coverage under the Company’s group medical and dental insurance plans pursuant to the Consolidated Omnibus Budget
Reconciliation Act of 1986, as amended (“COBRA”), for the period commencing on the date of Executive’s termination
and continuing until the earlier of the end of the six month period following his termination date or the first of the month
immediately following the Company’s receipt of notice from Executive terminating such coverage, Executive (and any qualified
dependents) will be entitled to coverage under such plans (as may be amended during the period of coverage) in which Executive was
participating immediately prior to the date of his termination of employment (the “COBRA Coverage”). The cost of the
premiums for such coverage will be borne by the Company, except that Executive will reimburse the Company for premiums becoming due
each month with respect to such coverage in an amount equal to the difference between the amount of such premiums and the portion
thereof currently being paid by Executive. Executive’s portion of such premiums will be payable by the first of each month
commencing the first month following the month in which his termination of employment occurs. The period during which Executive is
being provided with health insurance under this Agreement at the Company’s expense will be credited against Executive’s
period of COBRA coverage, if any. Further, if at any time during the period Executive is entitled to premium payments under this
Section 11(e), Executive becomes entitled to receive health insurance from a subsequent employer, the Company’s obligation to
continue premium payments to Executive shall terminate immediately.

 

    	8

     

    

 

12.
ADVICE TO PROSPECTIVE EMPLOYERS

 

If
Executive seeks or is offered employment by any other company, firm or person during his employment or during the post- termination restricted
periods, he will notify the prospective employer of the existence and terms of the non-competition and confidentiality agreements set
forth in Sections 7 and 9 of this Agreement. Executive may disclose the language of Sections 7 and 9 but may not disclose the remainder
of this Agreement.

 

13.
CHANGE IN CONTROL

 

(a)
In the event of a Change in Control (as defined herein) of the Parent, (i) all stock options, restricted stock, and all other equity
awards granted to Executive prior to the Change in Control will immediately vest in full, (ii) if, within 90 days prior to a Change
in Control, the Company terminates the employment of Executive for reasons other than for Good Cause, death or Continued Disability,
or Executive terminates employment for Good Reason, then, the Company will (x) pay the Executive the sum of (A) accrued but unpaid
salary through the termination date (paid in accordance with the normal practices of the Company), (B) expenses incurred by
Executive prior to his termination date for which Executive is entitled to reimbursement under (and paid in accordance with) Section
4 herein, and (C) provided that Executive is not in default of his obligations under Section 7, 8, or 9 herein, an amount equal to
twelve months’ base salary ((A) through (C), being hereinafter referred to, collectively, as the “Change in Control
Separation Benefits”) and (y) provide the COBRA Coverage, and all other stock options, restricted stock, and other equity
awards granted to Executive will immediately vest in full as of the date of termination and will remain exercisable until the
earlier of the end of the applicable option period or one hundred and eighty (180) days from the date of Executive’s
termination of employment, and (iii) if, within 12 months following a Change in Control, the Company terminates the employment of
Executive for reasons other than for Good Cause, death or Continued Disability or Executive terminates employment for Good Reason,
then (a) the Company will provide the Change in Control Separation Benefits and the COBRA Coverage, and (b) all stock options,
restricted stock, and other equity awards granted to Executive will immediately vest in full as of the date of termination and will
remain exercisable until the earlier of the end of the applicable option period or one hundred and eighty (180) days from the date
of Executive’s termination of employment. In the event Executive seeks to terminate his employment for Good Reason, such
termination will not be treated for purposes of this Section 13 as a termination for Good Reason unless Executive follows the
substantive and timing requirements for a termination for Good Reason as set forth in Section 11(d), including providing notice to
the Company and resigning within the proper time-frame following the Company’s failure to remedy the condition about which
Executive provided notice of Good Reason.

 

(b)
For purposes of this Agreement, “Change in Control” means any of the following events:

 

(i)
A change in control of the direction and administration of Parent’s business of a nature that would be required to be reported
in response to Item 6(e) of Schedule 14A of Regulation 14A promulgated under the Exchange Act, as in effect on the date hereof and
any successor provision of the regulations under the Exchange Act, whether or not Parent is then subject to such reporting
requirements; or

 

(ii)
Any “person” (as such term is used in Section 13(d) and Section 14(d)(2) of the Exchange Act but excluding any employee
benefit plan of Parent) is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly
or indirectly, of securities of Parent representing more than one half of the combined voting power of Parent’s outstanding
securities then entitled to vote for the election of directors; or

 

(iii)
Parent sells all or substantially all of the assets of Parent; or

 

    	9

     

    

 

(iv)
The consummation of a merger, reorganization, consolidation or similar business combination that constitutes a change in control as defined
in Parent’s 2013 Second Amended and Restated Stock Incentive Plan or other successor stock plan or results in the occurrence of
any event described in Sections 13(b) (i), (ii) or (iii) above.

 

(c)
Notwithstanding anything to the contrary contained in this Agreement, in the event any amounts payable hereunder would be considered
to be excess parachute payments for purposes of the amount payable following the occurrence of a Change in Control that is treated
as a “change in the ownership or effective control” of Parent or “in the ownership of a substantial portion of the
assets” of Parent for purposes of Code Sections 280G and 4999, those payments that are treated for purposes of Code Section
280G as being contingent on a “change in the ownership or effective control” (as that phrase is used for purposes of
Code Section 280G) of Streamline will be reduced, if and to the extent necessary, so that no payments under this Agreement are
treated as excess parachute payments.

 

14.
ACKNOWLEDGEMENTS

 

The
Company and Executive each hereby acknowledge and agree as follows:

 

(a)
The covenants, restrictions, agreements and obligations set forth herein are founded upon valuable consideration, and, with respect
to the covenants, restrictions, agreements and obligations set forth in Sections 7, 8 and 9 hereof, are reasonable in duration,
scope of restricted activity, and geographic scope;

 

(b)
In the event of a breach or threatened breach by Executive of any of the covenants, restrictions, agreements and obligations set
forth in Sections 7, 8 or 9 hereof, monetary damages or the other remedies at law that may be available to the Company for such
breach or threatened breach will be inadequate and, without prejudice to the Company’s right to pursue any other remedies at
law or in equity available to it for such breach or threatened breach, including, without limitation, the recovery of damages from
Executive, the Company will be entitled to injunctive relief from a court of competent jurisdiction or the arbitrator;
and

 

(c)
The time period, scope of restricted activity, and geographical area set forth in Section 9 hereof are each divisible and separable,
and, in the event that the covenants not to compete contained therein are judicially held invalid or unenforceable as to such time
period, scope of activities, or geographical area, they will be valid and enforceable to such extent and in such geographical
area(s) and for such time period(s) which the court determines to be reasonable and enforceable. Executive agrees that in the event
any court of competent jurisdiction determines that the above covenants are invalid or unenforceable to join with the Company in
requesting that court to construe the applicable provision by limiting or reducing it so as to be enforceable to the extent
compatible with the then applicable law. Furthermore, any period of restriction or covenant herein stated will not include any
period of violation or period of time required for litigation to enforce such restriction or covenant.

 

(d)
For purposes of this Section 14, the term “Company” shall be deemed to include Parent and the Company’s
Affiliates.

 

    	10

     

    

 

15.
NOTICES

 

Any
notice or communication required or permitted hereunder will be given in writing and will be sufficiently given if delivered personally
or sent by telecopy to such party addressed as follows:

 

(a)
In the case of the Company, if addressed to it as follows:

 

Streamline
Health Solutions, Inc.

10800
Amber Park Drive

Suite
125

Alpharetta,
Georgia 30009

Attn:
Chief Executive Officer

 

(b)
In the case of Executive, if addressed to Executive at the most recent address on file with the Company.

 

Any
such notice delivered personally will be deemed to have been received on the date of such delivery. Any address for the giving of notice
hereunder may be changed by notice in writing.

 

16.
NON-INTERFERENCE

 

Notwithstanding
anything to the contrary set forth in this Agreement or in any other agreement between Executive and the Company, nothing in this Agreement
or in any other agreement shall limit Executive’s ability, or otherwise interfere with Executive’s rights, to (a) file a
charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and
Health Administration, the Securities and Exchange Commission, or any other federal, state, or local governmental agency or commission
(each a “Government Agency”), (b) communicate with any Government Agency or otherwise participate in any investigation or
proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the
Company, (c) receive an award for information provided to any Government Agency, or (d) engage in activity specifically protected by
Section 7 of the National Labor Relations Act, or any other federal or state statute or regulation.

 

17.
ASSIGNMENT, SUCCESSORS AND ASSIGNS

 

This
Agreement will inure to the benefit of and be binding upon the parties hereto and their respective legal representatives, successors
and assigns. The Company may assign or otherwise transfer its rights under this Agreement to any successor or affiliated business or
corporation (whether by sale of stock, merger, consolidation, sale of assets or otherwise), but this Agreement may not be assigned, nor
may his duties hereunder be delegated, by Executive. In the event that the Company assigns or otherwise transfers its rights under this
Agreement to any successor or affiliated business or corporation (whether by sale of stock, merger, consolidation, sale of assets or
otherwise), for all purposes of this Agreement, the “Company” will then be deemed to include the successor or affiliated
business or corporation to which the Company assigned or otherwise transferred its rights hereunder.

 

18.
MODIFICATION

 

This
Agreement may not be released, discharged, abandoned, changed or modified in any manner, except by an instrument in writing signed by
each of the parties hereto.

 

19.
SEVERABILITY

 

The
invalidity or unenforceability of any particular provision of this Agreement will not affect any other provisions hereof, and the parties
will use their best efforts to substitute a valid, legal and enforceable provision, which, insofar as practical, implements the purpose
of this Agreement. If the parties are unable to reach such agreement, then the provisions will be modified as set forth in Section 14(c)
above. Any failure to enforce any provision of this Agreement will not constitute a waiver thereof or of any other provision hereof.

 

    	11

     

    

 

20.
COUNTERPARTS

 

This
Agreement may be signed in counterparts (and delivered via facsimile transmission or by digitally scanned signature delivered electronically),
and each of such counterparts will constitute an original document and such counterparts, taken together, will constitute one and the
same instrument.

 

21.
ENTIRE AGREEMENT

 

This
constitutes the entire agreement among the parties with respect to the subject matter of this Agreement and supersedes all prior and
contemporaneous agreements, understandings, and negotiations, whether written or oral, with respect to such subject matter, including
but not limited to that certain Employee Proprietary Information and Invention Agreement, dated August 9, 2021, and that certain Employment
Confidential Information and Invention Assignment Agreement, dated August 9, 2021.

 

22.
DISPUTE RESOLUTION

 

Except
as set forth in Section 14 above, any and all disputes arising out of or in connection with the execution, interpretation, performance
or non-performance of this Agreement or any agreement or other instrument between, involving or affecting the parties (including the
validity, scope and enforceability of this arbitration clause), will be submitted to and resolved by arbitration. The arbitration will
be conducted pursuant to the terms of the Federal Arbitration Act and the Employment Arbitration Rules and Mediation Procedures of the
American Arbitration Association. Either party may notify the other party at any time of the existence of a controversy potentially requiring
arbitration by certified mail, and the parties will attempt in good faith to resolve their differences within fifteen (15) days after
the receipt of such notice. If the dispute cannot be resolved within the fifteen-day period, either party may file a written demand for
arbitration with the American Arbitration Association. The place of arbitration will be mutually agreed by the parties.

 

	/s/
    JS	 	/s/
    TJG
	Initialed
    by Executive	 	Initialed
    by the Company

 

23.
GOVERNING LAW; FORUM SELECTION

 

The
provisions of this Agreement will be governed by and interpreted in accordance with the internal laws of the State of Georgia and the
laws of the United States applicable therein. Executive acknowledges and agrees that Executive is subject to personal jurisdiction in
state and federal courts in Fulton County, Georgia, and waives any objection thereto.

 

24.
CODE SECTION 409A

 

Notwithstanding
any other provision in this Agreement to the contrary, if and to the extent that Code Section 409A is deemed to apply to any benefit
under this Agreement, it is the general intention of the Company that such benefits will, to the extent practicable, comply with, or
be exempt from, Code Section 409A, and this Agreement will, to the extent practicable, be construed in accordance therewith. Deferrals
of benefits distributable pursuant to this Agreement that are otherwise exempt from Code Section 409A in a manner that would cause Code
Section 409A to apply will not be permitted unless such deferrals follow Code Section 409A. In the event that the Company (or a successor
thereto) has any stock which is publicly traded on an established securities market or otherwise and Executive is determined to be a
“specified employee” (as defined under Code Section 409A), any payment that is deemed to be deferred compensation under Code
Section 409A to be made to the Executive upon a separation from service may not be made before the date that is six months after Executive’s
separation from service (or death, if earlier). To the extent that Executive becomes subject to the six-month delay rule, all payments
that would have been made to Executive during the six months following his separation from service that are not otherwise exempt from
Code Section 409A, if any, will be accumulated and paid to Executive during the seventh month following his separation from service,
and any remaining payments due will be made in their ordinary course as described in this Agreement. For the purposes herein, the phrase
“termination of employment” or similar phrases will be interpreted in accordance with the term “separation from service”
as defined under Code Section 409A if and to the extent required under Code Section 409A. Further, (i) in the event that Code Section
409A requires that any special terms, provisions or conditions be included in this Agreement, then such terms, provisions and conditions
will, to the extent practicable, be deemed to be made a part of this Agreement, and (ii) terms used in this Agreement will be construed
in accordance with Code Section 409A if and to the extent required. Further, in the event that this Agreement or any benefit thereunder
will be deemed not to comply with Code Section 409A, then neither the Company, the Board, the Committee nor its or their designees or
agents will be liable to any participant or other person for actions, decisions or determinations made in good faith.

 

25.
WITHHOLDING.

 

The
Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as will be required to
be withheld pursuant to any applicable law or regulation.

 

[Signature
page follows.]

 

    	12

     

    

 

IN
WITNESS WHEREOF, this Agreement has been executed by the parties hereto to be effective as of the Effective Date.

 

	 	COMPANY:
	 	 	 
	 	AVELEAD
    CONSULTING, LLC
	 	 	 
	 	By:
    	/s/
    Jawad Shaikh
	 	Name:
    	Jawad
    Shaikh
	 	Title:
    	Executive
    Director

 

	 	EXECUTIVE:
	 	 
	 	/s/
    Jawad Shaikh
	 	Jawad
    Shaikh
	 	P.O.
    Box 839
	 	Suwanee,
    Ga 30024-0028
	 	jwshaikh@outlook.com

 

[Signature Page to Employment Agreement]

 

    	 

     

    

 

EXHIBIT
A TO EMPLOYMENT AGREEMENT (“AGREEMENT”) DATED AS OF THE EFFECTIVE DATE, BETWEEN AVELEAD CONSULTING, LLC AND JAWAD SHAIKH
— COMPENSATION AND BENEFITS

 

	1.	Start
                                            Date. Executive’s start date will be the same as the Effective Date (as such term
                                            as used in the Agreement), and is expected to be August 16, 2021.

 

	2.	Base
                                            Salary. Base Salary will be paid at an annualized rate of $340,000, which will be subject
                                            to annual review and adjustment by the CEO but will not be reduced below $340,000 without
                                            the consent of Executive. Such amounts will be payable to Executive in accordance with the
                                            normal payroll practices of the Company.

 

	3.	Annual
                                            Bonus. Target annual bonus and target goals will be set by the CEO and based on a combination
                                            of individual and Company performance. Target annual bonus will begin effective as of the
                                            Company’s fiscal year ending January 31, 2022, and will be set at a rate of 40% of
                                            Executive’s Base Salary, as may be increased from time-to-time. The annual bonus will
                                            be paid pursuant to such conditions as are established by the Company’s Annual Bonus
                                            Program, to the extent payable under a bonus plan, subject to such terms and conditions as
                                            may be set out in such plan. The annual bonus will, if payable, be paid in cash no later
                                            than March 15th of the fiscal year following the fiscal year during which Executive’s
                                            right to the annual bonus vests.

 

	4.	Benefits.
                                            Executive will be eligible to participate in the Company’s benefit plans on the same
                                            terms and conditions as provided for other Company executives, subject to all terms and conditions
                                            of such plans as they may be amended from time to time and will accrue vacation days and
                                            personal days totaling an aggregate of 20 days per annum prorated for 2021.

 

	5.	Grant
                                            of Stock Options. Executive will receive a grant of 500,000 stock options representing
                                            the Parent common stock under Parent’s 2013 Second Amended and Restated 2013 Stock
                                            Compensation Plan at strike price of the closing price the day before the Effective Date.
                                            The grant of 500,000 shares will be upon Executive’s hire date referred to in paragraph
                                            1 above. The vesting of such shares will be in twelve substantially equal quarterly installments
                                            over the first three years of employment commencing on November 16, 2021. Such grant will
                                            be made pursuant to and otherwise subject to the terms and conditions of Parent’s Second
                                            Amended and Restated 2013 Stock Incentive Plan and the Stock Option Agreement for Employees.

 

    	 

     

    

 

EXHIBIT
B TO EMPLOYMENT AGREEMENT (“AGREEMENT”) DATED AS OF THE EFFECTIVE DATE, BETWEEN AVELEAD CONSULTING, LLC AND JAWAD SHAIKH
— EXEMPTED ENTITIES

 

	1.	Peachtree
                                            Tech Village, LLC
	2.	American
                                            Global Education Group, LLC
	3.	AUSOMA,
                                            LLC

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]